Zhaoke Ophthalmology (06622) Announces Increase in Issued Shares and Confirms Public Float Compliance

Bulletin Express
03/03

Zhaoke Ophthalmology Limited (06622) released a monthly update for February 2026, reporting an authorized share capital of 1.60 trillion ordinary shares, each with a par value of USD 0.00000025, totaling USD 400,000. The issued share count rose from 547.97 million shares to 548.75 million shares, an increase of 0.78 million shares. The company confirmed that its public float remains above the required 25% threshold.

According to the filing, 779,000 new shares were issued during the month through the exercise of share options, generating HKD 621,434.25. No treasury shares or other convertible instruments were involved in the period. The update also notes official acknowledgement that all issued securities comply with relevant listing and regulatory requirements.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10